While it is stated that approximately 1 in 3 men with type 2 diabetes have hypogonadism, Australias’ University of Adelaide researchers published the largest study ever conducted.
Physiologically, testosterone levels in men gradually decrease as age progresses, and there are many studies on the relationship between this condition and type 2 diabetes. Now, scientists have researched that testosterone injections reduce the risk of type 2 diabetes.
Approximately 1 in 3 men with type 2 diabetes have hypogonadism (Hypogonadism is the name given to low serum testosterone levels biochemically and physiologically low testicular volume.) in subjects aged 50 to 74 and overweight or obese).
The researchers divided the subjects into 2 groups, and the first group received regular injections of testosterone every 3 months, while the other group received a placebo injection. In addition, 30% of the subjects (with the participation from both groups) were included in the exercise program.
As a result of the 2-year study, it was stated that individuals in both groups lost 4 kilos on average and there was an increase in the number of erythrocytes as a side effect in the group receiving testosterone injection, but this rate was stated to be 22% in the group receiving hormone injection. In addition, at the end of the 2-year period, the percentage of developing type 2 diabetes was 12% in the group that was injected with testosterone, while this rate was 21% in the group receiving placebo.
In addition to all these, let’s add that the fasting blood glucose levels of the treated group were lower, mild improvements were observed in sexual functions, and a slight increase was observed in muscle mass.